Prediction of aneurysm formation in vascular grafts of biologic origin.

[1]  F. Pilotto,et al.  Residual heteroantigenicity of glutaraldehyde-treated porcine cardiac valves. , 2008, Tissue antigens.

[2]  D. C. Brewster,et al.  Mural degeneration in the glutaraldehyde-tanned umbilical vein graft: incidence and implications. , 1986, Journal of vascular surgery.

[3]  G. L’italien,et al.  Compliance changes in glutaraldehyde-treated arteries. , 1986, The Journal of surgical research.

[4]  G. L’italien,et al.  Noninvasive measurements of nonlinear arterial elasticity. , 1986, The American journal of physiology.

[5]  A. H. Boontje.  Aneurysm formation in human umbilical vein grafts used as arterial substitutes. , 1985, Journal of vascular surgery.

[6]  J. Tew,et al.  Human umbilical artery for microvascular grafting. Experimental study in the rat. , 1984, Journal of neurosurgery.

[7]  R. King,et al.  Early aneurysmal degeneration of human umbilical vein bypass grafts , 1984, The British journal of surgery.

[8]  D. Loisance,et al.  Vascular substitute from human placental arteries: glycosaminoglycan and elastin synthesis in the neo-intimal hyperplasia. , 1984, Life support systems : the journal of the European Society for Artificial Organs.

[9]  H. V. Van Wart,et al.  Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography. , 1984, Biochemistry.

[10]  W H Baker,et al.  Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. , 1984, Archives of surgery.

[11]  R. Baier,et al.  Biodegradation and Aneurysm Formation in Umbilical Vein Grafts: Observations and a Realistic Strategy , 1984, Annals of surgery.

[12]  J. Cranley,et al.  Revascularization of the femoropopliteal arteries using saphenous vein, polytetrafluoroethylene, and umbilical vein grafts. Five- and six-year results. , 1982, Archives of surgery.

[13]  J. M. Keshishian,et al.  Aneurysm formation in human umbilical vein grafts. , 1982, Surgery.

[14]  D. Wa,et al.  Further experiences with bovine arterial grafts. , 1976 .

[15]  T. Fogarty,et al.  Antigenicity of vascular heterografts. , 1973, The Journal of surgical research.

[16]  J. Thompson,et al.  The modified bovine arterial graft. , 1972, Archives of surgery.

[17]  C. H. Sparks.  Die‐Grown Reinforced Arterial Grafts: Observations on Long‐term Animal Grafts and Clinical Experience , 1970, Annals of surgery.

[18]  B. Catchpole.  A NEW ARTERIAL PROSTHESIS , 1960 .

[19]  Leeds Fh,et al.  The prediction of healing in ischemic lesions of the foot. A comparison of Doppler ultrasound and elevation reactive hyperemia. , 1985 .

[20]  A. Harjula,et al.  Glutaraldehyde-processed human veins as small vessel substitutes. , 1985, VASA. Zeitschrift fur Gefasskrankheiten.

[21]  L. Sauvage,et al.  Glutaraldehyde preparation of coronary artery bypass bioprostheses. , 1985, The Journal of surgical research.

[22]  D. Williams,et al.  Biocompatibility of tissue analogs , 1985 .

[23]  R. Guidoin,et al.  New alternatives in the preparation of chemically fixed human umbilical veins as arterial substitutes. , 1982, Biomaterials, medical devices, and artificial organs.

[24]  L. Perloff,et al.  A new replacement for small vessels. , 1981, Surgery.

[25]  W. Barker,et al.  The current status of femoropopliteal bypass for arteriosclerotic occlusive disease: a panel discussion. , 1976, Surgery.

[26]  N. Rosenberg.  The bovine arterial graft and its several applications. , 1976, Surgery, gynecology & obstetrics.